Clinically relevant enhancement of human sperm motility using compounds with reported phosphodiesterase inhibitor activity.

Clinically relevant enhancement of human sperm motility using compounds with reported phosphodiesterase inhibitor activity.

Item
http://www.wikidata.org/entity/Q35784435
Extracellular vesicle-mediated delivery of molecular compounds into gametes and embryos: learning from natureFibroblast Growth Factor Receptors (FGFRs) in Human Sperm: Expression, Functionality and Involvement in Motility RegulationSpermaurin, an La1-like peptide from the venom of the scorpion Scorpio maurus palmatus, improves sperm motility and fertilization in different mammalian species.Specific loss of CatSper function is sufficient to compromise fertilizing capacity of human spermatozoa.Drug discovery for male subfertility using high-throughput screening: a new approach to an unsolved problem.Pentoxifylline besides naltrexone recovers morphine-induced inflammation in male reproductive system of rats by regulating Toll-like receptor pathway.Papaverine-sensitive phosphodiesterase activity is measured in bovine spermatozoa.Depolarization of sperm membrane potential is a common feature of men with subfertility and is associated with low fertilization rate at IVF.CASAnova: a multiclass support vector machine model for the classification of human sperm motility patterns.Characteristics of testis-specific phosphoglycerate kinase 2 and its association with human sperm quality.Anti-Müllerian hormone in serum and seminal plasma in comparison with other male fertility parameters.Single-cell analysis of [Ca2+]i signalling in sub-fertile men: characteristics and relation to fertilization outcome.The activity of seminal creatine kinase is increased in the presence of pentoxifylline.
P2860

Clinically relevant enhancement of human sperm motility using compounds with reported phosphodiesterase inhibitor activity.

Item
http://www.wikidata.org/entity/Q35784435
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Clinically relevant enhancemen ...... diesterase inhibitor activity.
@ast
Clinically relevant enhancemen ...... diesterase inhibitor activity.
@en
type
label
Clinically relevant enhancemen ...... diesterase inhibitor activity.
@ast
Clinically relevant enhancemen ...... diesterase inhibitor activity.
@en
prefLabel
Clinically relevant enhancemen ...... diesterase inhibitor activity.
@ast
Clinically relevant enhancemen ...... diesterase inhibitor activity.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Clinically relevant enhancemen ...... odiesterase inhibitor activity
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932